Literature DB >> 2824400

Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions.

B R Ksander1, R L Hendricks.   

Abstract

We have investigated the involvement of cell-mediated immune responses to Herpes simplex virus type 1 (HSV-1) in the pathogenesis of HSV-1 induced corneal stromal lesions in mice. Topical corneal (TC) HSV-1 infection induced a vigorous delayed hypersensitivity response, as well as lymphoproliferative and cytotoxic responses in the regional lymph nodes. The cytotoxic response involved HSV-1 specific and genetically restricted cytotoxic T lymphocytes, and activated natural killer cells. Half of the TC HSV-1 infected mice developed corneal stromal inflammation and scarring, the cause of visual morbidity in human herpetic disease. However, injection of HSV-1 into the ocular anterior chamber (AC) prior to, or simultaneously with, TC HSV-1 infection resulted in a profound state of cell-mediated immune tolerance of HSV-1 antigens. The tolerance was characterized by a substantial reduction in delayed hypersensitivity, lymphoproliferative, and cytotoxic responses to HSV-1 and was associated with virtually complete protection from corneal stromal lesions induced by HSV-1. These findings suggest a pathogenetic role for cell-mediated immunity and indicate the feasibility of preventing stromal disease through proper manipulation of the immune response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824400

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

1.  Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice.

Authors:  E Chang; L Galle; D Maggs; D M Estes; W J Mitchell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo.

Authors:  Sariah J Allen; Kevin R Mott; Homayon Ghiasi
Journal:  Exp Eye Res       Date:  2014-04-24       Impact factor: 3.467

Review 3.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

4.  Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology.

Authors:  C K Newell; S Martin; D Sendele; C M Mercadal; B T Rouse
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.

Authors:  Dirk Bauer; Andreas Schmitz; Nico Van Rooijen; Klaus-Peter Steuhl; Arnd Heiligenhaus
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

7.  A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.

Authors:  Likun Xia; Shengnan Zhang; Jiazi Zhou; Yan Li
Journal:  Mol Vis       Date:  2010-10-13       Impact factor: 2.367

8.  Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.

Authors:  M M Bartik; M C Ahn; B A Baumgartel; R L Hendricks; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.

Authors:  J L Benson; J Y Niederkorn
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

10.  Modulation of CD8+ CTL effector function by fibroblasts derived from the immunoprivileged cornea.

Authors:  Jared E Knickelbein; Sherrie Divito; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.